PDIA3 and breast carcinoma: PDIA3 over-expression in breast cancer correlates with poor clinical outcomes (Table 2), and our analysis of public data sets in the GOBO database showed that high expression of a gene signature corresponding to the extracellular protein set correlated with reduced distant metastasis-free survival of patients with basal-subtype breast cancer (134).